Berberine: a promising strategy to combat cetuximab-resistance in colorectal cancer

Retrieved on: 2025-10-06 13:59:57

Tags for this article:

Click the tags to see associated articles and topics

Berberine: a promising strategy to combat cetuximab-resistance in colorectal cancer. View article details on hiswai:

Excerpt

Cetuximab, a monoclonal antibody against epidermal growth factor receptor (EGFR), is approved as a front-line treatment for metastatic colorectal ...

Article found on: bmccancer.biomedcentral.com